cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Organovo Holdings Inc
15 own
18 watching
Current Price
$1.03
$-0.01
(-0.96%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
14.81M
52-Week High
52-Week High
2.05000
52-Week Low
52-Week Low
0.85000
Average Volume
Average Volume
0.05M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
35.1196
iconMarket Capitalization14.81M
icon52-Week High2.05000
icon52-Week Low0.85000
iconAverage Volume0.05M
iconDividend Yield--
iconP/E Ratio35.1196
What does the Organovo Holdings Inc do?
Organovo Holdings, Inc., an early commercial stage company, focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. It is developing a suite of standardized and three-dimensional human tissues for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion, and drug metabolism and pharmacokinetics; customized human tissues as living, dynamic models of human biology or disease for use in drug discovery and development; and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair, and functional tissue patches for the repair or replacement of damaged tissues and organs. The company has collaboration agreements with L'Oreal USA and Merck & Co. Organovo Holdings, Inc. was founded in 2007 and is headquartered in San Diego, California.
Read More
How much money does Organovo Holdings Inc make?
News & Events about Organovo Holdings Inc.
Globe Newswire
1 year ago
Lead Molecule Poised for Phase 2 in IBDSAN DIEGO, March 21, 2023 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), a clinical stage biotechnology company that is focused on developing novel human therapies with demonstrated function in high fidelity three-dimensional (3D) tissues that ...
Zolmax
1 year ago
Organovo Holdings, Inc. (NASDAQ:ONVO Get Rating) saw a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 291,600 shares, a decline of 11.1% from the February 13th total of 327,900 shares. Based on an average daily volume of 111,700 ...
Globe Newswire
1 year ago
SAN DIEGO, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional biology (3D biology) company focused on delivering scientific and medical breakthroughs using novel technologies including 3D bioprinting, today announced that it has successfully advanced the ...
Zolmax
2years ago
Renaissance Technologies LLC trimmed its position in shares of Organovo Holdings, Inc. (NASDAQ:ONVO Get Rating) by 21.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 120,887 shares of the ...
Frequently Asked Questions
Frequently Asked Questions
What is Organovo Holdings Inc share price today?
plus_minus_icon
Can Indians buy Organovo Holdings Inc shares?
plus_minus_icon
How can I buy Organovo Holdings Inc shares from India?
plus_minus_icon
Can Fractional shares of Organovo Holdings Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Organovo Holdings Inc stocks?
plus_minus_icon
What is today’s traded volume of Organovo Holdings Inc?
plus_minus_icon
What is today’s market capitalisation of Organovo Holdings Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Organovo Holdings Inc?
plus_minus_icon
What percentage is Organovo Holdings Inc down from its 52-Week High?
plus_minus_icon
What percentage is Organovo Holdings Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.03
$-0.01
(-0.96%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00